114 related articles for article (PubMed ID: 16633110)
1. Progression to cirrhosis in Latinos with chronic hepatitis C: differences in Puerto Ricans with and without human immunodeficiency virus coinfection and along gender.
Rodríguez-Torres M; Ríos-Bedoya CF; Rodríguez-Orengo J; Fernández-Carbia A; Marxuach-Cuétara AM; López-Torres A; Salgado-Mercado R; Bräu N
J Clin Gastroenterol; 2006 Apr; 40(4):358-66. PubMed ID: 16633110
[TBL] [Abstract][Full Text] [Related]
2. [Risk factors for the progression of chronic hepatitis C virus infection].
Valladares Alvarez G
Rev Gastroenterol Peru; 2003; 23(2):126-33. PubMed ID: 12853989
[TBL] [Abstract][Full Text] [Related]
3. Relating the liver damage with hepatitis C virus polymorphism in core region and human variables in HIV-1-coinfected patients.
Matas M; Picornell A; Cifuentes C; Payeras A; Bassa A; Homar F; López-Labrador FX; Moya A; Ramon MM; Castro JA
Infect Genet Evol; 2010 Dec; 10(8):1252-61. PubMed ID: 20732459
[TBL] [Abstract][Full Text] [Related]
4. Progression of chronic hepatitis C to liver fibrosis and cirrhosis in patients coinfected with hepatitis C virus and human immunodeficiency virus.
Martinez-Sierra C; Arizcorreta A; Díaz F; Roldán R; Martín-Herrera L; Pérez-Guzmán E; Girón-González JA
Clin Infect Dis; 2003 Feb; 36(4):491-8. PubMed ID: 12567308
[TBL] [Abstract][Full Text] [Related]
5. Risk of developing specific AIDS-defining illnesses in patients coinfected with HIV and hepatitis C virus with or without liver cirrhosis.
d'Arminio Monforte A; Cozzi-Lepri A; Castagna A; Antinori A; De Luca A; Mussini C; Caputo SL; Arlotti M; Magnani G; Pellizzer G; Maggiolo F; Puoti M;
Clin Infect Dis; 2009 Aug; 49(4):612-22. PubMed ID: 19591597
[TBL] [Abstract][Full Text] [Related]
6. Liver fibrosis progression is related to CD4 cell depletion in patients coinfected with hepatitis C virus and human immunodeficiency virus.
Puoti M; Bonacini M; Spinetti A; Putzolu V; Govindarajan S; Zaltron S; Favret M; Callea F; Gargiulo F; Donato F; Carosi G;
J Infect Dis; 2001 Jan; 183(1):134-7. PubMed ID: 11087200
[TBL] [Abstract][Full Text] [Related]
7. The influence of human immunodeficiency virus coinfection on chronic hepatitis C in injection drug users: a long-term retrospective cohort study.
Di Martino V; Rufat P; Boyer N; Renard P; Degos F; Martinot-Peignoux M; Matheron S; Le Moing V; Vachon F; Degott C; Valla D; Marcellin P
Hepatology; 2001 Dec; 34(6):1193-9. PubMed ID: 11732009
[TBL] [Abstract][Full Text] [Related]
8. Estimating progression to cirrhosis in chronic hepatitis C virus infection.
Freeman AJ; Dore GJ; Law MG; Thorpe M; Von Overbeck J; Lloyd AR; Marinos G; Kaldor JM
Hepatology; 2001 Oct; 34(4 Pt 1):809-16. PubMed ID: 11584380
[TBL] [Abstract][Full Text] [Related]
9. Natural history of hepatic fibrosis progression in chronic hepatitis C virus infection in India.
Hissar SS; Kumar M; Tyagi P; Goyal A; Suneetha PV; Agarwal S; Rastogi A; Sakhuja P; Sarin SK
J Gastroenterol Hepatol; 2009 Apr; 24(4):581-7. PubMed ID: 19032460
[TBL] [Abstract][Full Text] [Related]
10. [Chronic hepatitis C virus infection and associated liver disease among the inmates of a Spanish prison].
Murcia J; Portilla J; Bedia M; Palazón JM; Sánchez-Payá J; Saiz de la Hoya P; Payá A; Boix V; Merino E; Reus S
Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):206-12. PubMed ID: 19246126
[TBL] [Abstract][Full Text] [Related]
11. Human immunodeficiency virus and hepatitis C virus coinfection: epidemiology, natural history, therapeutic options and clinical management.
Verucchi G; Calza L; Manfredi R; Chiodo F
Infection; 2004 Feb; 32(1):33-46. PubMed ID: 15007741
[TBL] [Abstract][Full Text] [Related]
12. Liver fibrosis in patients with chronic hepatitis C and persistently normal liver enzymes: influence of HIV infection.
Martin-Carbonero L; de Ledinghen V; Moreno A; Maida I; Foucher J; Barreiro P; Romero M; Satta G; Garcia-Samaniego J; Gonzalez-Lahoz J; Soriano V
J Viral Hepat; 2009 Nov; 16(11):790-5. PubMed ID: 19413693
[TBL] [Abstract][Full Text] [Related]
13. Natural history of hepatitis C virus infection: from chronic hepatitis to cirrhosis, to hepatocellular carcinoma.
Leone N; Rizzetto M
Minerva Gastroenterol Dietol; 2005 Mar; 51(1):31-46. PubMed ID: 15756144
[TBL] [Abstract][Full Text] [Related]
14. Impact of human immunodeficiency virus infection on the prevalence and severity of steatosis in patients with chronic hepatitis C virus infection.
Gaslightwala I; Bini EJ
J Hepatol; 2006 Jun; 44(6):1026-32. PubMed ID: 16618518
[TBL] [Abstract][Full Text] [Related]
15. Puerto Rican injection drug users: Prevention implications in Massachusetts and Puerto Rico.
López LM; Zerden Lde S; Fitzgerald TC; Lundgren LM
Eval Program Plann; 2008 Feb; 31(1):64-73. PubMed ID: 17870164
[TBL] [Abstract][Full Text] [Related]
16. [A study of the progression of cirrhosis in patients with human immunodeficiency virus and hepatitis C virus coinfection].
Zhang YH; Chen XY; Wu H; Diao SQ
Zhonghua Gan Zang Bing Za Zhi; 2005 Apr; 13(4):264-6. PubMed ID: 15850512
[TBL] [Abstract][Full Text] [Related]
17. Chronic hepatitis C in ethnic minority patients evaluated in Los Angeles County.
Bonacini M; Groshen MD; Yu MC; Govindarajan S; Lindsay KL
Am J Gastroenterol; 2001 Aug; 96(8):2438-41. PubMed ID: 11513187
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of chronic hepatitis C virus genotypes among patients between 21 to 65 years old in Puerto Rico.
Rodríguez-Pérez F; Suárez-Pérez E; Alvarez-Rohena M; Toro DH
P R Health Sci J; 2004 Jun; 23(2 Suppl):49-56. PubMed ID: 16929587
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis C virus and glucose and lipid metabolism.
Alaei M; Negro F
Diabetes Metab; 2008 Dec; 34(6 Pt 2):692-700. PubMed ID: 19195632
[TBL] [Abstract][Full Text] [Related]
20. Liver cirrhosis in HIV-infected patients: prevalence, aetiology and clinical outcome.
Castellares C; Barreiro P; Martín-Carbonero L; Labarga P; Vispo ME; Casado R; Galindo L; García-Gascó P; García-Samaniego J; Soriano V
J Viral Hepat; 2008 Mar; 15(3):165-72. PubMed ID: 18233989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
